Suchergebnisse - "Huoponen, Saara"

PubPharm (8)

1

Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study

enthalten in: BMC psychiatry | 2022

von Taipale, H. | Lähteenvuo, M. | Tanskanen, A. | +3

2

Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland – a matched cohort study

enthalten in: BMC psychiatry | 2022

von Taipale, H. | Lähteenvuo, M. | Tanskanen, A. | +3

3

Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland – a matched cohort study

enthalten in: BMC psychiatry | 2022

von Taipale, H. | Lähteenvuo, M. | Tanskanen, A. | +3

4

Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease

enthalten in: Medicine | 2020

von Huoponen, S. | Eberl, A. | Räsänen, P. | +4

5

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis

enthalten in: PloS one | 2019

von Huoponen, S. | Aaltonen, K. | Viikinkoski, J. | +6

6

Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

enthalten in: Scandinavian journal of gastroenterology | 2017

von Eberl, A. | Huoponen, S. | Pahikkala, T. | +3

7

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis : a systematic review

enthalten in: PloS one | 2015

von Joensuu, J. | Huoponen, S. | Aaltonen, K. | +3

8

A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases

enthalten in: PloS one | 2015

von Huoponen, S. | Blom, M.

1
[1]